Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessBioNTech Could Make New Vaccine in 6 Weeks if Current Vaccine is...

BioNTech Could Make New Vaccine in 6 Weeks if Current Vaccine is Ineffective

Add to Favorite
Added to Favorite

 

 

 

BioNTech’s CEO Ugur Sahin has said that he is confident that its current coronavirus vaccine will work effectively against the new variant in the virus, traced to the UK. He also believed that further studies were required.

On Tuesday, the chief executive said that “We don’t know at the moment if our vaccine is also able to provide protection against this new variant.” The new variant has the same proteins, as much as 99% similar, as the previous ones and hence the vaccine maker has “scientific confidence” in its vaccine.

The company is conducting additional studies to confirm the efficacy of its vaccine.

He added, “The likelihood that our vaccine works is relatively high…” He also said that in a worst-case scenario that “we could be able to provide a new vaccine technically within six weeks.”

More than 45 countries worldwide have authorized the use of the vaccine jointly developed by Pharma giant Pfizer and German pharmaceutical company BioNTech. The vaccine began its rollout in the U.S. and the UK. European Union nations are planning to begin vaccinations on December 27, 2020.

Moderna, another pharmaceutical company who has developed a different, effective vaccine, is also testing it on the new UK variant, a strain that has a faster rate of transmission.

Subscribe to get Latest News Updates

Latest News

You may like more
more

JPMorgan’s 2025 Global Economic Outlook: Resilience Amid Risks

Introduction JPMorgan’s latest "2025 Global Economic Outlook" projects a resilient...

Trump’s Nominations Signal Market Volatility: Insights from Piper Sandler

Key Takeaways from Piper Sandler’s Report 1. Increased Policy Uncertainty Piper...

Stock Market Update: Dow Rebounds Despite Target’s Slump

Introduction The stock market experienced a volatile session but closed...